Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable lipase/esterase LipN | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | esterase LipW | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | lipase/esterase LipN | 0.0137 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.8075 | 1 | 1 |
Leishmania major | ecotin, putative | 0.0137 | 0 | 0.5 |
Trypanosoma cruzi | Isoprenylcysteine alpha-carbonyl methylesterase, putative | 0.0137 | 0 | 0.5 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.8075 | 1 | 1 |
Brugia malayi | aryl-acylamidase | 0.0137 | 0 | 0.5 |
Trypanosoma brucei | Isoprenylcysteine alpha-carbonyl methylesterase, putative | 0.0137 | 0 | 0.5 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.8075 | 1 | 1 |
Mycobacterium tuberculosis | Probable acetyl-hydrolase/esterase LipR | 0.0137 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable esterase LipO | 0.0137 | 0 | 0.5 |
Onchocerca volvulus | 0.0137 | 0 | 0.5 | |
Mycobacterium ulcerans | lipase LipU | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | esterase LipC | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | esterase/lipase | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | carboxylesterase LipQ | 0.0137 | 0 | 0.5 |
Toxoplasma gondii | alpha/beta hydrolase fold domain-containing protein | 0.0137 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable lipase LipH | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | lipase LipI | 0.0137 | 0 | 0.5 |
Treponema pallidum | N-acetylphosphinothricin-tripetide-deacetylase | 0.0137 | 0 | 0.5 |
Trichomonas vaginalis | Esterase, putative | 0.0137 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | esterase LipO | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | membrane-bound esterase LipM | 0.0137 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible esterase LipW | 0.0137 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable esterase/lipase LipF | 0.0137 | 0 | 0.5 |
Mycobacterium tuberculosis | Putative acetyl hydrolase MbtJ | 0.0137 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable carboxylesterase LipQ | 0.0137 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable non lipolytic carboxylesterase NlhH | 0.0137 | 0 | 0.5 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9D | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0137 | 0 | 0.5 |
Trypanosoma cruzi | Alpha/beta hydrolase domain-containing protein | 0.0137 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable esterase LipM | 0.0137 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | lipase LipH | 0.0137 | 0 | 0.5 |
Schistosoma mansoni | hormone-sensitive lipase (S09 family) | 0.8075 | 1 | 1 |
Mycobacterium ulcerans | lipase LipU | 0.0137 | 0 | 0.5 |
Mycobacterium ulcerans | acetyl hydrolase MbtJ | 0.0137 | 0 | 0.5 |
Echinococcus multilocularis | hormone sensitive lipase | 0.8075 | 1 | 0.5 |
Mycobacterium tuberculosis | Possible lipase LipU | 0.0137 | 0 | 0.5 |
Trypanosoma cruzi | Isoprenylcysteine alpha-carbonyl methylesterase, putative | 0.0137 | 0 | 0.5 |
Toxoplasma gondii | alpha/beta hydrolase fold domain-containing protein | 0.0137 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable esterase LipC | 0.0137 | 0 | 0.5 |
Trichomonas vaginalis | Esterase, putative | 0.0137 | 0 | 0.5 |
Trichomonas vaginalis | Esterase, putative | 0.0137 | 0 | 0.5 |
Mycobacterium leprae | Possible lipase LipU | 0.0137 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.28 uM | In vitro inhibitory activity against LTB4 synthesis in A-23,187 stimulated human whole blood (HB1). | ChEMBL. | No reference |
IC50 (functional) | = 0.28 uM | In vitro inhibitory activity against LTB4 synthesis in A-23,187 stimulated human whole blood (HB1). | ChEMBL. | No reference |
pKa | = 7.68 | pKa value of the compound was evaluated | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.